Related references
Note: Only part of the references are listed.A review on metronidazole: an old warhorse in antimicrobial chemotherapy
David Leitsch
PARASITOLOGY (2019)
Genotyping of Trichomonas vaginalis isolates from Egypt
Basant O. Mohamed et al.
PARASITOLOGISTS UNITED JOURNAL (2019)
In Vitro Study of the Susceptibility of Clinical Isolates of Trichomonas vaginalis to Metronidazole and Secnidazole
Arindam P. Ghosh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge
Jackie Sherrard et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2018)
Genetic Indicators of Drug Resistance in the Highly Repetitive Genome of Trichomonas vaginalis
Martina Bradic et al.
GENOME BIOLOGY AND EVOLUTION (2017)
In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates
Aida A. Abdel-Magied et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2017)
The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population
Aida A. Abdel-Magied et al.
PARASITOLOGY RESEARCH (2017)
Investigation of In Vitro Metronidazole Resistance in the Clinical Isolates of Trichomonas vaginalis
Hatice Ertabaklar et al.
MIKROBIYOLOJI BULTENI (2016)
A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections
Elissa Meites et al.
CLINICAL INFECTIOUS DISEASES (2015)
Epidemiology and Treatment of Trichomoniasis
Patricia Kissinger
CURRENT INFECTIOUS DISEASE REPORTS (2015)
Trichomonas vaginalis flavin reductase 1 and its role in metronidazole resistance
David Leitsch et al.
MOLECULAR MICROBIOLOGY (2014)
Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009-2010
Robert D. Kirkcaldy et al.
EMERGING INFECTIOUS DISEASES (2012)
Utility of Antimicrobial Susceptibility Testing in Trichomonas vaginalis-Infected Women With Clinical Treatment Failure
Elizabeth A. Bosserman et al.
SEXUALLY TRANSMITTED DISEASES (2011)
Trichomonas vaginalis Prevalence, Incidence, Risk Factors and Antibiotic-Resistance in an Adolescent Population
Jamie W. Krashin et al.
SEXUALLY TRANSMITTED DISEASES (2010)
Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea
Jacqueline A. Upcroft et al.
SEXUAL HEALTH (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women
Patricia Kissinger et al.
CLINICAL INFECTIOUS DISEASES (2008)
Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole
Jane R. Schwebke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer
Siobhan Sutcliffe et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Recalcitrant Trichomonas vaginalis infection -: a case series
LJ Waters et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2005)
In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis
AL Crowell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus
P Moodley et al.
CLINICAL INFECTIOUS DISEASES (2002)
Loss of multiple hydrogenosomal proteins associated with organelle metabolism and high-level drug resistance in trichomonads
KM Land et al.
EXPERIMENTAL PARASITOLOGY (2001)
Share Paper
